![](/img/cover-not-exists.png)
Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting
Dong M. Shin, Paul Y. Holoye, William K. Murphy, Arthur Forman, Sozos C. PapasozomenosVolume:
29
Year:
1991
Language:
english
Pages:
5
DOI:
10.1007/bf00687325
File:
PDF, 1.05 MB
english, 1991